Heightened rates of both cardiovascular (CV) events and subclinical atherosclerosis,
documented by imaging and vascular function techniques are well established in systemic …

Introduction The systemic inflammatory nature of systemic lupus erythematosus (SLE) is well
patent not only in the diverse clinical manifestations of the disease but also in the increased …

Ageing is associated with an increased risk of developing noncommunicable diseases
(NCDs), such as diabetes and cardiovascular disease (CVD). The increased risk can be …

Systemic lupus erythematosus (SLE) patients display an increased risk of cardiovascular
disease (CVD). With the improved clinical management of other classical severe …

Systemic lupus erythematosus is a multiorgan autoimmune disease with a highly variable
clinical course, typically involving women in childbearing age. At present, many aspects of …

Objective The aim was to evaluate the most relevant cell populations involved in vascular
homeostasis as potential biomarkers of SLE-related cardiovascular disease (CVD). Methods …

Objective Due to the increased availability of effective treatments, patients with systemic
lupus erythematosus (SLE) now have longer survival times, and factors involved in …

Systemic lupus erythematosus is a chronic connective tissue disease associated with an
increased risk of premature atherosclerosis. It is estimated that approximately 10% of SLE …

Objectives Metabolic syndrome (MetS) is highly prevalent in patients with systemic lupus
erythematosus (SLE) and it has been associated with increased cardiovascular risk. We …

Cardiovascular diseases (CVD) are one of the leading causes of high mortality in patients
with systemic lupus erythematosus (SLE). The Framingham risk score and other traditional …